http://www.drshrutibhat.com/project-ventures.html http://www.drshrutibhat.com/index.html http://www.drshrutibhat.com/blog-library.html http://www.drshrutibhat.com/what-has-been-published-about-shruti.html http://www.drshrutibhat.com/publications.html http://www.drshrutibhat.com/rd-leadership-achivements.html http://www.drshrutibhat.com/affiliations.html http://www.drshrutibhat.com/patents.html http://www.drshrutibhat.com/achievements.html http://www.drshrutibhat.com/endorsements.html http://www.drshrutibhat.com/awards.html http://www.drshrutibhat.com/research-expertise.html http://www.drshrutibhat.com/galenical-research-expertise.html http://www.drshrutibhat.com/ndds-and-specialty-products.html http://www.drshrutibhat.com/patent-specialization.html http://www.drshrutibhat.com/consulting.html http://www.drshrutibhat.com/quality-by-design-qbd.html http://www.drshrutibhat.com/qualifications.html http://www.drshrutibhat.com/products.html http://www.drshrutibhat.com/visual-cv.html http://www.drshrutibhat.com/blog.html http://www.drshrutibhat.com/resources.html http://www.drshrutibhat.com/contact.html http://www.drshrutibhat.com/contact-form.html http://www.drshrutibhat.com/international-operations-expertise.html http://www.drshrutibhat.com/therapeutic-categories.html http://www.drshrutibhat.com/project-management.html http://www.drshrutibhat.com/nanotechnology.html http://www.drshrutibhat.com/key-differentiators.html http://www.drshrutibhat.com/potential-contributions.html http://www.drshrutibhat.com/novel-technologies-handled.html http://www.drshrutibhat.com/top-innovations.html http://www.drshrutibhat.com/technologies.html http://www.drshrutibhat.com/new-page.html http://www.drshrutibhat.com/contact-confirmation-page.html http://www.drshrutibhat.com/patent-specialization1.html http://www.drshrutibhat.com/formulation-development-and-rd-leadership-expertise.html http://www.drshrutibhat.com/2/post/2009/5/new-strides-in-formulation-development-and-technologies.html http://www.drshrutibhat.com/2/post/2009/5/new-strides-in-formulation-development-continued.html http://www.drshrutibhat.com/2/post/2009/5/new-challendes-in-peptide-protein-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/controlled-release-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/classification-and-terminology-in-controlled-release-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/per-oral-controlled-release-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/osmotic-controlled-release-drug-delivery-system.html http://www.drshrutibhat.com/2/post/2009/5/dental-and-ocular-controlled-release-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/transdermal-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/design-of-transdermal-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/vaginal-and-uterine-controlled-release-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/controlled-release-formulations-part-ii-novel-systems.html http://www.drshrutibhat.com/2/post/2009/5/controlled-release-methodologies.html http://www.drshrutibhat.com/2/post/2009/5/different-mechanisms-of-controlled-release-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/parenteral-controlled-release-drug-delivery-system.html http://www.drshrutibhat.com/2/post/2009/5/quality-control-and-regulatory-requirements-of-crdds.html http://www.drshrutibhat.com/2/post/2009/5/novel-oral-crdds.html http://www.drshrutibhat.com/2/post/2009/5/novel-crdds-with-prolonged-gastric-residence-time.html http://www.drshrutibhat.com/2/post/2009/5/novel-implant-crdds.html http://www.drshrutibhat.com/2/post/2009/5/controlled-release-formulations-part-iii-target-oriented-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/factors-governing-drug-targetting.html http://www.drshrutibhat.com/2/post/2009/5/pk-pd-considerations-in-design-of-targeted-dds.html http://www.drshrutibhat.com/2/post/2009/5/classification-classes-of-drug-targetting.html http://www.drshrutibhat.com/2/post/2009/5/platforms-for-drug-targetting.html http://www.drshrutibhat.com/2/post/2009/5/other-carriers-used-in-drug-targeting.html http://www.drshrutibhat.com/2/post/2009/5/soluble-macromolecular-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/factorial-designs-in-pelletization-and-bead-technology.html http://www.drshrutibhat.com/2/post/2009/5/evaluation-of-pellets-prepared-using-factorial-experimental-designs.html http://www.drshrutibhat.com/2/post/2009/5/mucosal-delivery-of-peptide-based-therapeutics-the-wave-of-future.html http://www.drshrutibhat.com/2/post/2009/5/chemistry-of-peptides.html http://www.drshrutibhat.com/2/post/2009/5/analytical-considerations-of-mucosal-drug-delivery-systems.html http://www.drshrutibhat.com/2/post/2009/5/potential-routes-for-mucosal-delivery-of-peptide-pharmaceuticals.html http://www.drshrutibhat.com/2/post/2009/5/nanotechnology-in-mucosal-dds.html http://www.drshrutibhat.com/2/post/2009/5/pulmonary-route-for-mucosal-drug-delivery-i.html http://www.drshrutibhat.com/2/post/2009/5/pulmonary-route-for-mucosal-drug-delivery-ii.html http://www.drshrutibhat.com/2/post/2009/5/intranasal-administration-for-proteins-peptide-mucosal-delivery.html http://www.drshrutibhat.com/2/post/2009/5/buccal-delivery-of-peptides-i.html http://www.drshrutibhat.com/2/post/2009/5/buccal-delivery-of-peptides-proteins-ii.html http://www.drshrutibhat.com/2/post/2009/5/rectal-delivery-of-peptides-for-mucosal-dds.html http://www.drshrutibhat.com/2/post/2009/5/colon-targeting-delivery-of-peptides-for-mucosal-dds.html http://www.drshrutibhat.com/2/post/2009/5/references-gallery-on-mucosal-drug-delivery-systems-i.html http://www.drshrutibhat.com/2/post/2009/5/references-gallery-on-mocosal-drug-delivery-systems-ii.html http://www.drshrutibhat.com/2/post/2009/5/references-gallery-on-mucosal-drug-delivery-systems-iii.html http://www.drshrutibhat.com/2/post/2009/5/references-gallery-for-mucosal-drug-delivery-systems-iv.html http://www.drshrutibhat.com/2/post/2009/5/mucosal-drug-delivery-systems-formulation-considerations-i.html http://www.drshrutibhat.com/2/post/2009/5/formulation-considerations-in-mucosal-drug-delivery-ii.html http://www.drshrutibhat.com/2/post/2009/5/formulation-considerations-in-mucosal-dds-iii.html http://www.drshrutibhat.com/2/post/2009/5/formulation-considerations-in-mucosal-drug-delivery-iv.html http://www.drshrutibhat.com/2/post/2009/5/pages-from-the-history-a-comparison-of-patent-laws-world-wide-i.html http://www.drshrutibhat.com/2/post/2009/5/pages-from-the-history-a-comparison-of-patent-laws-world-wide-ii.html http://www.drshrutibhat.com/2/post/2009/5/pages-from-the-history-a-comparison-of-patent-laws-world-wide-iii.html http://www.drshrutibhat.com/2/post/2009/5/pages-from-the-history-a-comparison-of-patent-laws-world-wide-iv.html http://www.drshrutibhat.com/2/post/2009/11/seo-mistakes-to-avoid.html http://www.drshrutibhat.com/2/post/2009/11/canada-and-the-us-differences-in-patent-law.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-new-anti-hiv-therapies.html http://www.drshrutibhat.com/2/post/2009/11/canadian-patent-law-an-introduction.html http://www.drshrutibhat.com/2/post/2009/11/canadian-patent-law-claims.html http://www.drshrutibhat.com/2/post/2009/11/candian-patent-law-types-of-claims.html http://www.drshrutibhat.com/2/post/2009/11/canadian-patent-law-patent-description-and-example.html http://www.drshrutibhat.com/2/post/2009/11/update-on-romidepsin-injection.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-updates.html http://www.drshrutibhat.com/2/post/2009/11/tips-to-improve-your-web-portal-design.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-update.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights1.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights2.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights3.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights4.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights5.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights6.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights7.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights8.html http://www.drshrutibhat.com/2/post/2009/11/drug-research-and-technology-highlights9.html http://www.drshrutibhat.com/2/post/2009/12/drug-research-and-technology-highlights10.html http://www.drshrutibhat.com/2/post/2009/12/the-505b2-drug-development-pathway.html http://www.drshrutibhat.com/2/post/2009/12/new-drug-approvals-highlights.html http://www.drshrutibhat.com/2/post/2009/12/fda-approves-qutenza-capsaicin-for-post-neuralgia-shingles.html http://www.drshrutibhat.com/2/post/2009/12/drug-research-and-technology-highlights11.html http://www.drshrutibhat.com/2/post/2009/12/drug-research-and-technology-highlights12.html http://www.drshrutibhat.com/2/post/2009/12/fda-approves-pennsaiddiclofenac-sodium-topical-solution.html http://www.drshrutibhat.com/2/post/2009/12/drug-research-and-technology-highlights13.html http://www.drshrutibhat.com/2/post/2009/12/business-of-medicine-update.html http://www.drshrutibhat.com/2/post/2009/12/quality-and-regulatory-affairs-update.html http://www.drshrutibhat.com/2/post/2009/12/build-a-digital-footprint-you-can-be-proud-of.html http://www.drshrutibhat.com/2/post/2009/12/three-important-canadian-patent-decisions-in-december-2009.html http://www.drshrutibhat.com/2/post/2009/12/fda-approves-first-generic-aricept-to-treat-dementia-related-to-alzheimers-disease.html http://www.drshrutibhat.com/2/post/2009/12/what-will-2010-bring-for-pharma-industry.html http://www.drshrutibhat.com/2/post/2009/12/do-you-know-what-is-blogging.html http://www.drshrutibhat.com/2/post/2009/12/time-management-tips.html http://www.drshrutibhat.com/2/post/2009/12/top-10-pharma-layoffs-in-2009.html http://www.drshrutibhat.com/2/post/2009/12/how-to-network-to-improve-your-net-worththe-golden-rule-of-networking.html http://www.drshrutibhat.com/2/post/2009/12/what-makes-someone-professional.html http://www.drshrutibhat.com/2/post/2009/12/are-you-a-leader-take-a-look-at-yourself-through-these-criteria-and-decide.html http://www.drshrutibhat.com/2/post/2009/12/how-they-managed-to-rise-to-the-top.html http://www.drshrutibhat.com/2/post/2009/12/drug-updates.html http://www.drshrutibhat.com/2/post/2009/12/quality-and-safety-updates.html http://www.drshrutibhat.com/2/post/2009/12/drug-research-updates1.html http://www.drshrutibhat.com/2/post/2009/12/drug-clinical-research-updates.html http://www.drshrutibhat.com/2/post/2009/12/drug-clinical-research-updates1.html http://www.drshrutibhat.com/2/post/2009/12/drug-clinical-research-updates2.html http://www.drshrutibhat.com/2/post/2009/12/drug-clinical-research-updates3.html http://www.drshrutibhat.com/2/post/2009/12/drug-clinical-research-updates4.html http://www.drshrutibhat.com/2/post/2009/12/drug-clinical-research-updates5.html http://www.drshrutibhat.com/2/post/2009/12/drug-clinical-research-updates6.html http://www.drshrutibhat.com/2/post/2010/1/drug-clinical-research-updates7.html http://www.drshrutibhat.com/2/post/2010/1/pharma-regulatory-updates.html http://www.drshrutibhat.com/2/post/2010/1/top-50-linkedin-groups-all-mbas-must-join.html http://www.drshrutibhat.com/2/post/2010/1/overcoming-discouragement-from-fired-to-inspired-to-hired.html http://www.drshrutibhat.com/2/post/2010/1/are-you-a-hunter-or-farmer.html http://www.drshrutibhat.com/2/post/2010/1/drug-clinical-research-updates8.html http://www.drshrutibhat.com/2/post/2010/1/pharma-regulatory-qa-updates.html http://www.drshrutibhat.com/2/post/2010/1/drug-clinical-research-updates9.html http://www.drshrutibhat.com/2/post/2010/1/post-title-click-and-type-to-edit1.html http://www.drshrutibhat.com/2/post/2010/1/pharma-business-updates.html http://www.drshrutibhat.com/2/post/2010/1/post-title-click-and-type-to-edit2.html http://www.drshrutibhat.com/2/post/2010/1/australian-patent-office-patent-term-extension-available-if-it-has-pharmaceutical-characteristics.html http://www.drshrutibhat.com/2/post/2010/1/drug-research-updates2.html http://www.drshrutibhat.com/2/post/2010/1/canada-cipos-new-draft-guidelines-could-result-in-higher-disclosure-standards-for-canadian-patents.html http://www.drshrutibhat.com/2/post/2010/1/drug-research-updates3.html http://www.drshrutibhat.com/2/post/2010/1/canada-canadian-patent-disclosure-requirements-clarified.html http://www.drshrutibhat.com/2/post/2010/1/who-are-the-50-best-employers-in-canada.html http://www.drshrutibhat.com/2/post/2010/1/clinical-research-updates.html http://www.drshrutibhat.com/2/post/2010/1/canadas-federal-court-of-appeal-limits-damages-available-to-delayed-generics.html http://www.drshrutibhat.com/2/post/2010/1/pharma-regulatory-updates1.html http://www.drshrutibhat.com/2/post/2010/1/cancer-drugs-clinical-research-updates.html http://www.drshrutibhat.com/2/post/2010/1/drug-clinical-research-updates10.html http://www.drshrutibhat.com/2/post/2010/1/drug-regulatory-updates.html http://www.drshrutibhat.com/2/post/2010/1/canada-the-patent-pendulum.html http://www.drshrutibhat.com/2/post/2010/1/pharmaceutical-rd-updates-clinical-research-happenings-of-new-drugs.html http://www.drshrutibhat.com/2/post/2010/2/ablynx-says-first-nanobody-drug-may-hit-market-by-2013.html http://www.drshrutibhat.com/2/post/2010/2/study-links-paxil-to-breast-cancer-patients-death.html http://www.drshrutibhat.com/2/post/2010/2/study-generic-nifedipine-product-not-bioequivalent-to-adalat-xl.html http://www.drshrutibhat.com/2/post/2010/2/clinical-research-updates-on-new-drugs.html http://www.drshrutibhat.com/2/post/2010/2/three-habits-of-job-seekers-who-get-hired-fast.html http://www.drshrutibhat.com/2/post/2010/2/pharma-business-news.html http://www.drshrutibhat.com/2/post/2010/2/pharmaceutical-rd-business-news-expert-updates.html http://www.drshrutibhat.com/2/post/2010/2/pharma-biz-news-update-pfizers-viagra-patent-partially-rejected.html http://www.drshrutibhat.com/2/post/2010/2/statins-may-increase-diabetes-risk-clinical-and-pharmaceutical-rd-updates.html http://www.drshrutibhat.com/2/post/2010/2/post-title-click-and-type-to-edit3.html http://www.drshrutibhat.com/2/post/2010/2/fda-clears-drug-to-treat-respiratory-symptoms-of-cystic-fibrosis.html http://www.drshrutibhat.com/2/post/2010/2/australian-innovation-patent-advantage-ignore-it-at-your-potential-peril.html http://www.drshrutibhat.com/2/post/2010/2/research-and-development-in-the-21st-century-web-enabled-innovation-comes-of-age.html http://www.drshrutibhat.com/2/post/2010/3/innovative-strategies-and-models-for-rd-success.html http://www.drshrutibhat.com/2/post/2010/3/marketing-your-career-be-a-proactive-job-seekerknow-what-is-personal-branding.html http://www.drshrutibhat.com/2/post/2010/3/six-genes-may-help-predict-paclitaxels-effectiveness-in-cancer-patients.html http://www.drshrutibhat.com/2/post/2010/3/heartburn-drug-renamed-to-avoid-medicinal-mix-ups.html http://www.drshrutibhat.com/2/post/2010/3/drug-counterfeits-continue-to-plague-middle-east-drug-quality-updates.html http://www.drshrutibhat.com/2/post/2010/3/are-selection-patents-new-business-challenges-for-researchers-and-companies-like.html http://www.drshrutibhat.com/2/post/2010/3/bristol-myers-has-60-potential-drugs-in-its-pipeline.html http://www.drshrutibhat.com/2/post/2010/3/what-is-the-future-of-medicine-what-are-the-lessons-from-60-years-of-pharmaceutical-innovation.html http://www.drshrutibhat.com/2/post/2010/3/fda-devising-new-guidelines-to-expedite-testing-approval-of-multidrug-regimens.html http://www.drshrutibhat.com/2/post/2010/3/strategies-to-prevent-heart-attacks-in-type-2-diabetes-patients-may-be-ineffective-harmful.html http://www.drshrutibhat.com/2/post/2010/3/drug-combination-meets-key-milestone-in-cancer-trial.html http://www.drshrutibhat.com/2/post/2010/3/workplace-incivility-on-the-rise-what-can-we-do-to-stop-it.html http://www.drshrutibhat.com/2/post/2010/3/walmart-coming-to-healthcare-minute-clinic-business-model-how-do-we-ensure-we-have-the-agility-insight-and-execution-in-order-to-survive-and-thrive-in-this-period-of-rapid-healthcare-pharmaceutical-change.html http://www.drshrutibhat.com/2/post/2010/4/social-media-networking-an-essential-skill-for-personal-branding-job-searching-many-more.html http://www.drshrutibhat.com/2/post/2010/4/roche-to-introduce-at-least-six-new-drugs-by-2015.html http://www.drshrutibhat.com/2/post/2010/4/whats-all-the-buzz-about-is-twitter-here-to-stay-does-it-really-provide-business-opportunity.html http://www.drshrutibhat.com/2/post/2010/4/advances-in-pharmaceutical-research-use-of-nano-technology-as-therapeutic-platforms-for-disease-management.html http://www.drshrutibhat.com/2/post/2010/4/-quasi-regulations-of-japanese-drug-market.html http://www.drshrutibhat.com/2/post/2010/4/fda-phasing-out-production-sale-of-cfc-asthma-inhalers.html http://www.drshrutibhat.com/2/post/2010/4/walmart-coming-into-healthcare-minute-clinic-business-model-how-do-we-ensure-we-have-the-agility-insight-and-execution-in-order-to-survive-and-thrive-in-this-period-of-rapid-healthcare-pharmaceutical-change.html http://www.drshrutibhat.com/2/post/2010/4/high-dose-aspirin-may-provide-acute-migraine-relief.html http://www.drshrutibhat.com/2/post/2010/4/vitamin-b6-appears-to-play-role-in-preventing-colon-cancer.html http://www.drshrutibhat.com/2/post/2010/4/information-modeling-for-pharmaceutical-product-development-life-cyle-management.html http://www.drshrutibhat.com/2/post/2010/4/tailored-treatment-based-on-tumors-molecular-traits-may-improve-lung-cancer-survival.html http://www.drshrutibhat.com/2/post/2010/4/fda-warns-companies-against-claiming-dietary-supplements-can-prevent-treat-h1n1.html http://www.drshrutibhat.com/2/post/2010/4/nanotechnology-a-new-tool-in-pharmaceutical-research.html http://www.drshrutibhat.com/2/post/2010/4/nanotechnology-in-pharmaceutical-research-magnetic-fields-drive-paclitaxel-loaded-nanoparticles-to-reduce-blood-vessel-blockages.html http://www.drshrutibhat.com/2/post/2010/4/fda-to-decide-on-therapeutic-cancer-vaccine.html http://www.drshrutibhat.com/2/post/2010/5/fda-approves-novel-asthma-treatment.html http://www.drshrutibhat.com/2/post/2010/5/updated-job-search-tips-mistakes-you-cant-afford-to-make.html http://www.drshrutibhat.com/2/post/2010/5/10-commandments-for-better-networking.html http://www.drshrutibhat.com/2/post/2010/5/pharmaceutical-rd-business-news-updates-glaxo-ceo-plans-to-announce-two-small-acquisitions-soon.html http://www.drshrutibhat.com/2/post/2010/5/8-ways-a-job-interview-can-take-a-turn-for-the-worse.html http://www.drshrutibhat.com/2/post/2010/5/united-arab-emirates-major-changes-to-uae-ip-laws-announced.html http://www.drshrutibhat.com/2/post/2010/5/follow-up-follow-up-follow-up-plus-1-more.html http://www.drshrutibhat.com/2/post/2010/5/where-do-job-leads-come-from-thats-what-most-job-seekers-want-to-know.html http://www.drshrutibhat.com/2/post/2010/5/health-canada-issues-warning-on-transdermal-patch.html http://www.drshrutibhat.com/2/post/2010/5/how-can-dominos-new-pizza-recipe-help-you-in-your-job-search.html http://www.drshrutibhat.com/2/post/2010/5/basic-science-may-not-be-translating-into-drug-approvals.html http://www.drshrutibhat.com/2/post/2010/5/liraglutide-added-to-metformin-may-benefit-patients-with-type-2-diabetes.html http://www.drshrutibhat.com/2/post/2010/5/shortened-research-path-for-cholesterol-drug.html http://www.drshrutibhat.com/2/post/2010/5/job-search-strategy-series-what-further-after-you-have-a-contact-name-from-linkedin.html http://www.drshrutibhat.com/2/post/2010/5/global-health-initiative-to-fund-battle-against-malaria-among-children-women-in-africa.html http://www.drshrutibhat.com/2/post/2010/6/blood-sugar-meter-that-connects-with-gaming-systems-may-help-children-with-diabetes.html http://www.drshrutibhat.com/2/post/2010/6/get-your-job-search-in-gear.html http://www.drshrutibhat.com/2/post/2010/6/drug-appears-to-shrink-tumors-in-lung-cancer-patients-with-a-certain-genetic-variation.html http://www.drshrutibhat.com/2/post/2010/6/post-title-click-and-type-to-edit4.html http://www.drshrutibhat.com/2/post/2010/6/finding-a-culture-for-success.html http://www.drshrutibhat.com/2/post/2010/6/the-first-big-win-against-skin-cancer-drug-boosts-survival-in-major-study-of-deadly-melanoma.html http://www.drshrutibhat.com/2/post/2010/6/how-to-take-days-off-your-job-search.html http://www.drshrutibhat.com/2/post/2010/6/quality-systems-approach-to-pharmaceutical-cgmp-quality-by-design-qbd.html http://www.drshrutibhat.com/2/post/2010/6/starpharma-plans-effectiveness-studies-on-herpes-killing-gel-for-women-pharmaceutical-rd-updates.html http://www.drshrutibhat.com/2/post/2010/6/ace-the-interview-meet-objectives-at-every-stage.html http://www.drshrutibhat.com/2/post/2010/6/leading-pharmaceutical-industry-news-biovail-and-valeant-pharmaceuticals-agree-to-merge-in-32-billion-deal.html http://www.drshrutibhat.com/2/post/2010/6/knowing-interview-styles-an-essential-criteria-of-career-management.html http://www.drshrutibhat.com/2/post/2010/6/after-12-months-aspirin-ok-without-plavix-for-patients-with-stents.html http://www.drshrutibhat.com/2/post/2010/6/pfizer-suspends-clinical-trials-of-tanezumab-as-potential-osteoarthritis-treatment.html http://www.drshrutibhat.com/2/post/2010/7/fda-approves-first-implantable-miniature-telescope-to-improve-sight-of-amd-patients.html http://www.drshrutibhat.com/2/post/2010/7/us-supreme-court-hedges-its-bets-on-business-methods-canadian-businesses-beware.html http://www.drshrutibhat.com/2/post/2010/7/did-you-wind-up-in-a-default-career.html http://www.drshrutibhat.com/2/post/2010/7/two-studies-suggest-diabetes-drug-avandia-increases-risk-of-heart-problems.html http://www.drshrutibhat.com/2/post/2010/7/tea-tree-oil-may-help-treat-some-skin-cancers.html http://www.drshrutibhat.com/2/post/2010/7/large-drugmakers-placing-new-emphasis-on-targeted-cancer-treatments.html http://www.drshrutibhat.com/2/post/2010/7/fda-approves-three-in-one-blood-pressure-drug.html http://www.drshrutibhat.com/2/post/2010/7/canada-approves-seasonal-flu-nasal-vaccine.html http://www.drshrutibhat.com/2/post/2010/7/apotex-vs-pfizer-in-lipitor-patent-challenge-an-interesting-case-study.html http://www.drshrutibhat.com/2/post/2010/7/eli-lilly-canada-v-novopharm-ltd-canadian-patent-act-contains-no-reference-to-invalidate-selection-patents.html http://www.drshrutibhat.com/2/post/2010/8/starting-hiv-therapy-earlier-may-help-reduce-mortality-risk-thwart-tb-infection.html http://www.drshrutibhat.com/2/post/2010/8/fda-approves-first-ever-human-test-of-embryonic-stem-cell-based-therapy.html http://www.drshrutibhat.com/2/post/2010/8/tracking-your-targets-know-super-tools-linkedin-and-google.html http://www.drshrutibhat.com/2/post/2010/8/patent-abstracts-for-canadian-patent-filings-must-be-made-available-in-both-official-languages-ie-english-and-french.html http://www.drshrutibhat.com/2/post/2010/8/fda-proposes-to-remove-orthostatic-hypotension-drug-from-market.html http://www.drshrutibhat.com/2/post/2010/8/misoprostol-may-be-as-effective-as-oxytocin-in-speeding-labor-for-women-with-inadequate-contractions.html http://www.drshrutibhat.com/2/post/2010/9/drug-recalls-in-usa-reached-a-record-high-1742-in-2009-why-so-many-recalls.html http://www.drshrutibhat.com/2/post/2010/11/cancer-drug-sales-fast-sliding.html http://www.drshrutibhat.com/2/post/2010/11/italy-disclosing-generics-applications-aifa-heading-for-greater-transparency.html http://www.drshrutibhat.com/2/post/2010/11/australia-not-all-patent-protection-is-equal-beware-ip-related-scams.html http://www.drshrutibhat.com/2/post/2010/11/blockbuster-antibodies-now-face-quick-onslaught-of-biosimilars.html http://www.drshrutibhat.com/2/post/2010/12/apotex-vs-astra-zeneca-court-finds-astrazeneca-patent-to-esomeprazole-nexium-invalid-for-lack-of-sound-prediction-and-obviousness.html http://www.drshrutibhat.com/2/post/2010/12/is-genzyme-history.html http://www.drshrutibhat.com/2/post/2010/12/former-fda-official-urges-agency-to-look-into-lasik.html http://www.drshrutibhat.com/2/post/2010/12/study-links-low-daily-dose-of-aspirin-to-reduced-bowel-cancer-risk.html http://www.drshrutibhat.com/2/post/2010/12/reformulation-trend-capturing-pharma.html http://www.drshrutibhat.com/2/post/2010/12/gut-microbes-could-offer-new-therapeutic-platform.html http://www.drshrutibhat.com/2/post/2010/12/apotex-vs-astra-zeneca-court-finds-astrazeneca-patent-to-esomeprazole-nexium-invalid-for-lack-of-sound-prediction-and-obviousness1.html http://www.drshrutibhat.com/2/post/2010/12/big-pharma-kisses-its-blockbuster-years-goodbye.html http://www.drshrutibhat.com/2/post/2010/12/how-will-expiring-drug-patents-affect-companies-in-the-healthcare-sector.html http://www.drshrutibhat.com/2/post/2010/12/is-hybrid-model-a-good-long-term-strategy-for-drug-makers.html http://www.drshrutibhat.com/2/post/2010/12/new-zealand-prior-art-searching-the-importance-of-due-diligence-in-rd-processes.html http://www.drshrutibhat.com/2/post/2010/12/mexican-patent-office-excludes-formulation-patents-from-linkage-gazette.html http://www.drshrutibhat.com/2/post/2010/12/united-kingdom-deadline-for-filing-of-divisional-patent-applications.html http://www.drshrutibhat.com/2/post/2011/1/drug-approvals-slipped-in-2010-some-potential-blockbusters-suffered-delays-amid-fdas-tougher-safety-stance.html http://www.drshrutibhat.com/3/post/2010/7/first-post.html http://www.drshrutibhat.com/3/post/2010/7/controlled-release-pharmaceuticals-part-1.html http://www.drshrutibhat.com/3/post/2010/7/controlled-release-pharmaceuticals-part-2.html http://www.drshrutibhat.com/3/post/2010/7/non-pareil-seeds-development-using-factorial-optimization-designs.html http://www.drshrutibhat.com/3/post/2010/7/japanese-pharmaceutical-industry-a-profile.html http://www.drshrutibhat.com/3/post/2010/7/quality-by-design-process-to-zero-defects-in-life-science-industry.html http://www.drshrutibhat.com/3/post/2010/7/claims-based-pharmaceutical-rd-model.html http://www.drshrutibhat.com/3/post/2010/7/pharmaceutical-rd-business-models.html http://www.drshrutibhat.com/3/post/2010/7/21st-century-pharmaceutical-rds.html http://www.drshrutibhat.com/3/post/2010/7/selection-patenting-in-canada.html http://www.drshrutibhat.com/3/post/2010/7/nanotechnology-applications-in-pharmaceuticals.html http://www.drshrutibhat.com/3/post/2010/7/global-pharmaceutical-industry-a-profile.html http://www.drshrutibhat.com/3/post/2010/7/usfda-approves-first-implantable-miniature-telescope-to-improve-sight-of-age-related-macular-degeneration-amd-patients.html http://www.drshrutibhat.com/3/post/2010/7/us-supreme-court-hedges-its-bets-on-business-methods-canadian-businesses-beware.html http://www.drshrutibhat.com/3/post/2010/7/cmc-post-approval-manufacturing-changes-draft-guidelines-issued-by-usfda.html http://www.drshrutibhat.com/3/post/2010/11/cancer-drug-sales-fast-sliding-ims-survey.html http://www.drshrutibhat.com/3/post/2010/11/italy-disclosing-generics-applications-aifa-heading-for-increased-transparency.html http://www.drshrutibhat.com/3/post/2010/11/canada-going-global-how-canadian-companies-view-intellectual-property-survey-results.html http://www.drshrutibhat.com/3/post/2011/1/key-developments-in-canada-patent-law-in-2010.html